Skip to main content
. 2025 Sep 25;12(10):380. doi: 10.3390/jcdd12100380

Table 2.

Pharmacological treatment at baseline.

General Characteristics Total
ACE-I (%) 30
ARBs (%) 0
BBs (%) 60
Diuretics (%) 100
CCBs (%) 10
Antiplatelets (%) 50
Anticoagulants (%) 50
Anti-arrhythmics (%) 30
Vaso-dilators (%) 0
Digoxin (%) 0
MRAs (%) 40
ARNI (%) 50
SGLUT-2 (%) 20
Tafamidis (%) 30